Urinary Stress Hormones, Hypertension, and Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
暂无分享,去创建一个
K. Watson | T. Seeman | T. Horwich | Kosuke Inoue | R. Bhatnagar | Karan Bhatt | D. Goldwater | Karan Bhatt
[1] ROBERT W. Johnson,et al. Multisite , 2020, Professional WordPress® Plugin Development.
[2] K. Watson,et al. Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium , 2020, Hypertension.
[3] M. Budoff,et al. Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis. , 2019, Atherosclerosis.
[4] S. Lightman,et al. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility , 2018, Stress.
[5] J. Spence,et al. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension , 2018, Annals of Internal Medicine.
[6] Andrew Steptoe,et al. Effects of stress on the development and progression of cardiovascular disease , 2018, Nature Reviews Cardiology.
[7] Joseph M Pappachan,et al. Pheochromocytomas and Hypertension , 2018, Current Hypertension Reports.
[8] D. Cruz-Topete,et al. Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System , 2017, International journal of molecular sciences.
[9] A. Isidori,et al. Complications of Cushing's syndrome: state of the art. , 2016, The lancet. Diabetes & endocrinology.
[10] P. Sever,et al. Urinary catecholamines and the relationship with blood pressure and pharmacological therapy , 2016, Journal of hypertension.
[11] Martin Reincke,et al. Subclinical hypercortisolism: a state, a syndrome, or a disease? , 2015, European journal of endocrinology.
[12] A. Sherwood,et al. Association of Depressive and Anxiety Symptoms With 24-Hour Urinary Catecholamines in Individuals With Untreated High Blood Pressure , 2015, Psychosomatic medicine.
[13] T. Seeman,et al. Associations of socioeconomic and psychosocial factors with urinary measures of cortisol and catecholamines in the Multi-Ethnic Study of Atherosclerosis (MESA) , 2014, Psychoneuroendocrinology.
[14] P. Hopkins,et al. PREDICTORS OF PLASMA AND URINARY CATECHOLAMINE LEVELS IN NORMOTENSIVE AND HYPERTENSIVE MEN AND WOMEN , 2013, Journal of Human Hypertension.
[15] A. Sherwood,et al. Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. , 2011, American journal of hypertension.
[16] I. Chiodini. Diagnosis and Treatment of Subclinical Hypercortisolism , 2011 .
[17] P. Jose,et al. Dopamine Receptors: Important Antihypertensive Counterbalance Against Hypertensive Factors , 2011, Hypertension.
[18] H. Jha,et al. Plasma circulatory markers in male and female patients with coronary artery disease. , 2010, Heart & lung : the journal of critical care.
[19] L. Scott,et al. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. , 2008, American journal of physiology. Renal physiology.
[20] Moyses Szklo,et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.
[21] P. Jose,et al. The dopaminergic system in hypertension. , 2007, Clinical science.
[22] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[23] Alexander Bucur,et al. Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging. , 2004, Social science & medicine.
[24] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[25] M. Kikuya,et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study , 2002, Journal of hypertension.
[26] G. Dibona,et al. Sympathetic nervous system and the kidney in hypertension , 2002, Current opinion in nephrology and hypertension.
[27] J. Whitworth,et al. Cushing, cortisol, and cardiovascular disease. , 2000, Hypertension.
[28] M. Lokhandwala,et al. THE ROLE OF INTRARENAL NITRIC OXIDE IN THE NATRIURETIC RESPONSE TO DOPAMINE-RECEPTOR ACTIVATION , 2000, Clinical and experimental hypertension.
[29] B. McEwen. Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.
[30] B. Morgenstern,et al. Human blood pressure determination by sphygmomanometry. , 1993, Circulation.
[31] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[32] P. Brennan,et al. Urinary catecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council trial for mild hypertension and from matched controls. , 1985, The Quarterly journal of medicine.
[33] D. Lake,et al. An improved technique for extracting catecholamines from body fluids , 1985, Journal of Neuroscience Methods.
[34] F. Fuchs,et al. Does psychosocial stress cause hypertension? A systematic review of observational studies , 2009, Journal of Human Hypertension.
[35] G. Brooks,et al. Catecholamine response is attenuated during moderate-intensity exercise in response to the "lactate clamp" , 2005 .
[36] Shumei Yang,et al. Glucocorticoids and vascular reactivity. , 2004, Current vascular pharmacology.
[37] T. Saruta,et al. Increased urinary dopamine excretion in young patients with essential hypertension. , 1994, Clinical and experimental hypertension.